<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:macqu="http://miacquisitionsinc.com/20170331">
    <link:schemaRef xlink:href="macqu-20170331.xsd" xlink:type="simple" />
    <xbrli:context id="From2017-01-01to2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-22to2015-04-23_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-22</xbrli:startDate>
        <xbrli:endDate>2015-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-04-23_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-22to2015-04-23_us-gaap_OverAllotmentOptionMember_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-22</xbrli:startDate>
        <xbrli:endDate>2015-04-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-11-10to2016-11-11_custom_FoundersSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">macqu:FoundersSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-11-10</xbrli:startDate>
        <xbrli:endDate>2016-11-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:UnderwritingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember_custom_MSPACHoldingsILLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:MSPACHoldingsILLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember_custom_ChardanCapitalMarketsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:UnderwritingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">macqu:ChardanCapitalMarketsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">macqu:UnitPurchaseOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">macqu:UnitPurchaseOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember_custom_DemandAndPiggyBackRegistrationRightsMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">macqu:UnitPurchaseOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:DemandAndPiggyBackRegistrationRightsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember_custom_DemandAndPiggyBackRegistrationRightsMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">macqu:UnitPurchaseOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:DemandAndPiggyBackRegistrationRightsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-12to2016-09-13_us-gaap_AffiliatedEntityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-12</xbrli:startDate>
        <xbrli:endDate>2016-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_AffiliatedEntityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_AffiliatedEntityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-12to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-12</xbrli:startDate>
        <xbrli:endDate>2016-10-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-13to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-13</xbrli:startDate>
        <xbrli:endDate>2016-10-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_AffiliatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:AffiliatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-18to2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-18</xbrli:startDate>
        <xbrli:endDate>2016-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-18to2016-09-19_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-18</xbrli:startDate>
        <xbrli:endDate>2016-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-19_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_IPOMember_custom_TrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:TrustAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:TrustAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:TrustAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:TrustAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_TrustAgreementMember_custom_OutsideTrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:TrustAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:OutsideTrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">macqu:TrustAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:InitialStockholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_USTreasurySecuritiesMember_custom_TrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:TrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-18to2016-09-19_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">macqu:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-18</xbrli:startDate>
        <xbrli:endDate>2016-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_UnsecuredDebtMember_us-gaap_AffiliatedEntityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-06-29to2015-07-01_custom_UnsecuredDebt1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">macqu:UnsecuredDebt1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-06-29</xbrli:startDate>
        <xbrli:endDate>2015-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_LoansPayableMember_us-gaap_AffiliatedEntityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-06-28to2016-06-30_us-gaap_UnsecuredDebtMember_us-gaap_AffiliatedEntityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:AffiliatedEntityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-06-28</xbrli:startDate>
        <xbrli:endDate>2016-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_UnsecuredDebt1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001653558</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">macqu:UnsecuredDebt1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2017-01-01to2017-03-31">M I Acquisitions, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2017-01-01to2017-03-31">0001653558</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2017-01-01to2017-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2017-01-01to2017-03-31">2017-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2017-01-01to2017-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2017-01-01to2017-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2017-01-01to2017-03-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2017-01-01to2017-03-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2017-01-01to2017-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2017-01-01to2017-03-31">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2017-01-01to2017-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2017-01-01to2017-03-31">2017</dei:DocumentFiscalYearFocus>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-05-12" unitRef="Shares" decimals="INF">7058743</dei:EntityCommonStockSharesOutstanding>
    <dei:TradingSymbol contextRef="From2017-01-01to2017-03-31">MACQU</dei:TradingSymbol>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">128071</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">362535</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-03-31" unitRef="USD" decimals="0">3233</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-03-31_custom_TrustAgreementMember_custom_OutsideTrustAccountMember" unitRef="USD" decimals="0">128000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">4731015</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">4748033</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">30000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">30000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">2327728</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">2310710</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValueOutstanding contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">2327728</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2310710</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdministrativeFeesExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdministrativeFeesExpense contextRef="From2016-09-12to2016-09-13_us-gaap_AffiliatedEntityMember" unitRef="USD" decimals="0">10000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2017-01-01to2017-03-31_us-gaap_AffiliatedEntityMember" unitRef="USD" decimals="0">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2016-01-01to2016-03-31_us-gaap_AffiliatedEntityMember" unitRef="USD" decimals="0">0</us-gaap:AdministrativeFeesExpense>
    <us-gaap:DirectOperatingCosts contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">215466</us-gaap:DirectOperatingCosts>
    <us-gaap:DirectOperatingCosts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">7264</us-gaap:DirectOperatingCosts>
    <us-gaap:OperatingExpenses contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">245466</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">7264</us-gaap:OperatingExpenses>
    <us-gaap:InvestmentIncomeInterest contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">56621</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">56621</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-188845</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-7264</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2017-01-01to2017-03-31" unitRef="USDPShares" decimals="INF">-0.08</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2016-01-01to2016-03-31" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-01-01to2017-03-31" unitRef="Shares" decimals="INF">2310710</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2016-01-01to2016-03-31" unitRef="Shares" id="Foot-00-0" decimals="INF">1250000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <macqu:FormationAndOrganizationCostsPaidByRelatedParties contextRef="From2017-01-01to2017-03-31" unitRef="USD" xsi:nil="true" />
    <macqu:FormationAndOrganizationCostsPaidByRelatedParties contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">5497</macqu:FormationAndOrganizationCostsPaidByRelatedParties>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">64964</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">4264</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-306166</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-1767</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <macqu:InterestReleasedFromTrustAccount contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-71702</macqu:InterestReleasedFromTrustAccount>
    <macqu:InterestReleasedFromTrustAccount contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">71702</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">-234464</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="0">-1767</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:ConversionOfStockAmountIssued1 contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">188845</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:ConversionOfStockAmountIssued1 contextRef="From2016-01-01to2016-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;1 &amp;#8212; Organization, Plan of Business Operations and Going Concern Consideration&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;M&#13;I Acquisitions, Inc. (the &amp;#8220;Company&amp;#8221;) was incorporated in Delaware on April 23, 2015 as a blank check company whose&#13;objective is to acquire, through a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization&#13;or other similar business combination, one or more businesses or entities (a &amp;#8220;Business Combination&amp;#8221;). The Company&amp;#8217;s&#13;efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although&#13;the Company intends to focus its search on target businesses operating in the technology, media and telecommunications industries.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;At&#13;March 31, 2017, the Company had not yet commenced any operations. &lt;font style="background-color: white"&gt;For the three months ended&#13;March 31, 2017, the Company&amp;#8217;s activity has been limited to the evaluation of business combination candidates, and the Company&#13;will not be generating any operating revenues until the closing and completion of an initial business combination.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;registration statement for the Company&amp;#8217;s initial public offering was declared effective on September 13, 2016. The Company&#13;consummated a public offering of 5,000,000 units (&amp;#8220;Units&amp;#8221;) on September 19, 2016 (the &amp;#8220;Offering&amp;#8221;), generating&#13;gross proceeds of $50,000,000 and net proceeds of $47,981,581 after deducting $2,018,419 of transaction costs. In addition, the&#13;Company generated gross proceeds of $4,025,000 from the private placement of 402,500 units (the &amp;#8220;Private Placement&amp;#8221;)&#13;to certain initial stockholders (&amp;#8220;Initial Stockholders&amp;#8221;) of the Company. The Units sold pursuant to the Offering and&#13;the Private Placement were sold at an offering price of $10.00 per Unit. &amp;#160;The Company also incurred additional issuance costs&#13;totaling $1,169,032, of which the deferred underwriting fee of $1,062,022 was unpaid as of March 31, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;underwriters exercised the over-allotment option in part and, on October 14, 2016, the underwriters purchased 310,109 Over-allotment&#13;Option Units, which were sold at an offering price of $10.00 per Unit, generating gross proceeds of $3,101,090 and net proceeds&#13;of $3,008,057 after deducting $93,033 of transaction costs.&amp;#160;On October 14, 2016, simultaneously with the sale of the over-allotment&#13;Units, the Company consummated the private sale of an additional 18,607 private Units to one of the initial stockholders, generating&#13;gross proceeds of $186,070.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Offering and&#13;Private Placement, although substantially all of the net proceeds are intended to be generally applied toward consummating a Business&#13;Combination. The Company&amp;#8217;s Units, common stock and warrants are listed on the Nasdaq Capital Market (&amp;#8220;NASDAQ&amp;#8221;).&#13;Pursuant to the NASDAQ listing rules, the Company&amp;#8217;s initial Business Combination must be with a target business or businesses&#13;whose collective fair market value is at least equal to 80% of the balance in the trust account at the time of the execution of&#13;a definitive agreement for such Business Combination, although this may entail simultaneous acquisitions of several target businesses.&#13;There is no assurance that the Company will be able to effect a Business Combination successfully.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Following&#13;the closing of the Offering and the Private Placement (including the partial exercise of the over-allotment option, an amount&#13;of $54,694,127 (or $10.30 per share sold to the public in the Offering included in the Units (&amp;#8220;Public Shares&amp;#8221;)) from&#13;the sale of the Units and Private Units is being held in a trust account (&amp;#8220;Trust Account&amp;#8221;) at J.P. Morgan Chase Bank&#13;maintained by American Stock Transfer &amp;#38; Trust Company, acting as trustee, and may be invested in money market funds meeting&#13;the applicable conditions of Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, and that invest solely&#13;in U.S. treasuries or United States bonds, treasuries or notes having a maturity of 180 days or less. The $54,694,127 placed into&#13;the Trust Account may not be released until the earlier of (i) the consummation of the Company&amp;#8217;s initial Business Combination&#13;and (ii) the Company&amp;#8217;s failure to consummate a Business Combination within the prescribed time. The remaining net proceeds&#13;(not held in the Trust Account) may be used to pay for business, legal and accounting due diligence on prospective acquisitions&#13;and continuing general and administrative expenses. Additionally, the interest earned on the Trust Account balance may be released&#13;to the Company to pay the Company&amp;#8217;s tax obligations. Placing funds in the Trust Account may not protect those funds from&#13;third party claims against the Company. Although the Company will seek to have all vendors, service providers, prospective target&#13;businesses or other entities it engages, execute agreements with the Company waiving any claim of any kind in or to any monies&#13;held in the Trust Account, there is no guarantee that such persons will execute such agreements. The Company&amp;#8217;s insiders&#13;will agree to be liable under certain circumstances to ensure that the proceeds in the Trust Account are not reduced by the claims&#13;of target businesses or vendors or other entities that are owed money by the Company for service rendered, contracted for or products&#13;sold to the Company. However, they may not be able to satisfy those obligations should they arise. With these exceptions, expenses&#13;incurred by the Company may be paid prior to a Business Combination only from the net proceeds of the Proposed Public Offering&#13;not held in the Trust Account; provided, however, that in order to meet its working capital needs following the consummation of&#13;the Proposed Public Offering, the Company&amp;#8217;s Initial Stockholders, officers and directors or their affiliates may, but are&#13;not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole&#13;discretion. Each loan would be evidenced by a promissory note. The notes would either be paid upon consummation of the Company&amp;#8217;s&#13;initial Business Combination, without interest, or, at the lender&amp;#8217;s discretion, up to $200,000 of the notes may be converted&#13;upon consummation of the Company&amp;#8217;s Business Combination into additional Private Units at a price of $10.00 per Unit. If&#13;the Company does not complete a Business Combination, the loans would not be repaid.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company will either seek stockholder approval of any Business Combination at a meeting called for such purpose at which stockholders&#13;may seek to convert their shares into their pro rata share of the aggregate amount then on deposit in the Trust Account, less&#13;any taxes then due but not yet paid, or provide stockholders with the opportunity to sell their shares to the Company by means&#13;of a tender offer for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, less&#13;any taxes then due but not yet paid. The Company will proceed with a Business Combination only if it will have net tangible assets&#13;of at least $5,000,001 upon consummation of the Business Combination and, solely if stockholder approval is sought, a majority&#13;of the outstanding common shares of the Company voted are voted in favor of the Business Combination. Notwithstanding the foregoing,&#13;a public stockholder, together with any affiliate of his or any other person with whom he is acting in concert or as a &amp;#8220;group&amp;#8221;&#13;(as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking conversion rights with respect to 20% or&#13;more of the common shares sold in the Offering. Accordingly, all shares purchased by a holder in excess of 20% of the shares sold&#13;in the Offering will not be converted to cash.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;connection with any stockholder vote required to approve any Business Combination, the Initial Stockholders agreed (i) to vote&#13;any of its respective shares, including the common shares sold to the Initial Stockholders in connection with the organization&#13;of the Company (the &amp;#8220;Initial Shares&amp;#8221;), common shares included in the Private Units sold in the Private Placement,&#13;and any common shares which were initially issued in connection with the Offering, whether acquired in or after the effective&#13;date of the Offering, in favor of the initial Business Combination and (ii) not to convert such respective shares into a pro rata&#13;portion of the Trust Account or seek to sell their shares in connection with any tender offer the Company engages in.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant&#13;to the Company&amp;#8217;s amended and restated Certificate of Incorporation if the Company is unable to complete its initial Business&#13;Combination within 18 months from the date of the Offering, the Company will (i) cease all operations except for the purpose of&#13;winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding&#13;public shares and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining&#13;holders of common stock and the Company&amp;#8217;s board of directors, dissolve and liquidate. However, if the Company anticipates&#13;that it may not be able to consummate its initial Business Combination within 18 months, the Company may extend the period of&#13;time to consummate a Business Combination up to three times, each by an additional month (for a total of up to 21 months to complete&#13;a Business Combination). Pursuant to the terms of the Company&amp;#8217;s amended and restated articles of incorporation and the trust&#13;agreement entered into between the Company and American Stock Transfer &amp;#38; Trust Company, in order to extend the time available&#13;for the Company to consummate its initial Business Combination, the Company&amp;#8217;s insiders or their affiliates or designees,&#13;upon five days advance notice prior to the applicable deadline, must deposit into the trust account $132,753 ($0.025 per unit),&#13;up to an aggregate of $398,259, or $0.075 per unit, on or prior to the date of the applicable deadline, for each one month extension.&#13;In the event that the Company receives notice from its insiders five days prior to the applicable deadline of their intent to&#13;effect an extension, the Company intends to issue a press release announcing such intention at least three days prior to the applicable&#13;deadline. In addition, the Company intends to issue a press release the day after the applicable deadline announcing whether or&#13;not the funds had been timely deposited. The Company&amp;#8217;s insiders and their affiliates or designees are not obligated to fund&#13;the trust account to extend the time for the Company to complete its initial Business Combination. To the extent that some, but&#13;not all, of the Company&amp;#8217;s insiders, decide to extend the period of time to consummate the initial Business Combination,&#13;such insiders (or their affiliates or designees) may deposit the entire $398,259. If the Company is unable to consummate an initial&#13;Business Combination and is forced to redeem 100% of the outstanding public shares for a pro rata portion of the funds held in&#13;the Trust Account, each holder will receive a pro rata portion of the amount then in the Trust Account. Holders of warrants will&#13;receive no proceeds in connection with the liquidation. The Initial Stockholders and the holders of Private Units will not participate&#13;in any redemption distribution with respect to their initial shares and Private Units, including the common stock included in&#13;the Private Units.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;To&#13;the extent the Company is unable to consummate a business combination, the Company will pay the costs of liquidation from the&#13;remaining assets outside of the trust account. If such funds are insufficient, the insiders have agreed to pay the funds necessary&#13;to complete such liquidation (currently anticipated to be no more than $15,000) and have agreed not to seek repayment of such&#13;expenses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Going&#13;Concern&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern, which contemplates,&#13;among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of March 31,&#13;2017, the Company had approximately $128,000 in cash and cash equivalents held outside Trust Account, approximately $56,600 in&#13;interest income available from the Company's investments in the Trust Account to pay its tax obligations, and working capital&#13;of approximately $95,000. Further, the Company has incurred and expects to continue to incur significant costs in pursuit of its&#13;financing and acquisition plans. The Company&amp;#8217;s plans to raise capital or to consummate the initial Business Combination&#13;may not be successful.&amp;#160; These matters, among others, raise substantial doubt about the Company&amp;#8217;s ability to continue&#13;as a going concern.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Based&#13;on the foregoing, the Company may have insufficient funds available to operate its business through the earlier of consummation&#13;of a Business Combination or March 19, 2018 (if an extension is not completed). &amp;#160;Following the initial Business Combination,&#13;if cash on hand is insufficient, the Company may need to obtain additional financing in order to meet its obligations. &amp;#160;The&#13;Company cannot be certain that additional funding will be available on acceptable terms, or at all.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying condensed financial statements do not include any adjustments that might be necessary if the Company is unable to&#13;continue as a going concern.&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;2 &amp;#8212; Significant Accounting Policies&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis&#13;of presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally&#13;accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;) and pursuant to the rules and regulations of the Securities&#13;and Exchange Commission (&amp;#8220;SEC&amp;#8221;) for interim financial information and the instructions to Form 10-Q. Accordingly,&#13;they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments&#13;(consisting of normal accruals) considered for a fair presentation have been included. The Company has evaluated subsequent events&#13;through the issuance of this Form 10-Q. Operating results for the quarter ended March 31, 2017 are not necessarily indicative&#13;of the results that may be expected for the year ended December 31, 2017 or any future interim period. The accompanying unaudited&#13;condensed financial statements should be read in conjunction with the Company&amp;#8217;s financial statements and notes thereto included&#13;in the Company&amp;#8217;s Form 10-K filed with the Securities and Exchange Commission on March 13, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Emerging&#13;Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Section&#13;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting&#13;standards until private companies (that is, those that have not had a Securities Act registration statement declared effective&#13;or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial&#13;accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with&#13;the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has&#13;elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different&#13;application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard&#13;at the time private companies adopt the new or revised standard. This may make comparison of the Company&amp;#8217;s financial statement&#13;with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of&#13;using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash&#13;and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Marketable&#13;securities held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;amounts held in the Trust Account represent substantially all of the proceeds of the Initial Public Offering and are classified&#13;as restricted assets since such amounts can only be used by the Company in connection with the consummation of a Business Combination.&#13;As of March 31, 2017, marketable securities held in the Trust Account consisted of $54,716,747 in United States Treasury Bills&#13;with an original maturity of six months or less. During the three months ended March 31, 2017, the Company withdrew interest income&#13;totaling $71,702 to be utilized for payment of tax obligations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Fair&#13;value of financial instruments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of the Company&amp;#8217;s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards&#13;Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 820, &amp;#8220;&lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;,&amp;#8221;&#13;approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Deferred&#13;Offering Costs&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&amp;#8220;SAB&amp;#8221;) Topic 5A&amp;#8212;&amp;#8220;&lt;i&gt;Expenses&#13;of Offering&lt;/i&gt;.&amp;#8221; Deferred offering costs consist of costs incurred in connection with preparation for the Offering. These&#13;costs, together with the underwriter discount, were charged to capital upon completion of the Offering.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use&#13;of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect&#13;the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial&#13;statements. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentration&#13;of credit risk&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Financial&#13;instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution&#13;which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these&#13;accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Net&#13;Loss Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common&#13;shares outstanding during the period, plus, to the extent dilutive, the incremental number of shares of common stock to settle&#13;warrants, as calculated using the treasury stock method. An aggregate of 4,731,015 shares of common stock subject to possible&#13;redemption at March 31, 2017 and an aggregate of 187,500 shares subject to forfeiture if the over-allotment option was not exercised&#13;in full by the underwriters at March 31, 2016, have been excluded from the calculation of basic loss per ordinary share since&#13;such shares, if redeemed, only participate in their pro rata share of the trust earnings.&amp;#160;At March 31, 2017, the Company&#13;did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock&#13;and then share in the earnings of the Company under the treasury stock method. As a result, diluted loss per common share is the&#13;same as basic loss per common share for the period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Common&#13;stock subject to possible conversion&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for its common stock subject to possible conversion in accordance with the guidance enumerated in ASC 480 &amp;#8220;&lt;i&gt;Distinguishing&#13;Liabilities from Equity&lt;/i&gt;&amp;#8221;.&amp;#160;&amp;#160;&amp;#160;Common stock subject to mandatory conversion are classified as a liability&#13;instrument and is measured at fair value. Conditionally convertible common stock (including common shares that feature conversion&#13;rights that are either within the control of the holder or subject to conversion upon the occurrence of uncertain events not solely&#13;within the Company&amp;#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&amp;#8217;&#13;equity. The Company&amp;#8217;s common stock features certain conversion rights that are considered by the Company to be outside of&#13;the Company&amp;#8217;s control and subject to the occurrence of uncertain future events. Accordingly, the common stock subject to&#13;possible conversion is presented as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s&#13;condensed balance sheet.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income&#13;Taxes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for income taxes under ASC 740 &amp;#8220;&lt;i&gt;Income Taxes&lt;/i&gt;&amp;#8221;. ASC 740 requires the recognition of deferred&#13;tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets&#13;and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally&#13;requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets&#13;will not be realized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ASC&#13;740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&amp;#8217;s financial statements and&#13;prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position&#13;taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not&#13;to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest&#13;and penalties, accounting in interim periods, disclosure and transition. The Company is required to file income tax returns in&#13;the United States (federal) and in various state and local jurisdictions. Based on the Company&amp;#8217;s evaluation, it has been&#13;concluded that there are no significant uncertain tax positions requiring recognition in the Company&amp;#8217;s financial statements.&#13;Since the Company was incorporated on April 23, 2015, the evaluation was performed for the 2015 and 2016 tax year. The Company&#13;believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that&#13;would result in a material change to its financial position.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s policy for recording interest and penalties associated with audits is to record such expense as a component of&#13;income tax expense. There were no amounts accrued for penalties or interest as of or during the period from January 1, 2017 through&#13;March 31, 2017. Management is currently unaware of any issues under review that could result in significant payments, accruals&#13;or material deviations from its position.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Related&#13;Parties&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company follows subtopic ASC 850-10 for the identification of related parties and disclosure of related party transactions.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant&#13;to Section 850-10-20, the related parties include: (a.) affiliates of the Company (&amp;#8220;Affiliate&amp;#8221; means, with respect&#13;to any specified Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled&#13;by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act);&#13;(b.) entities for which investments in their equity securities would be required, absent the election of the fair value option&#13;under the Fair Value Option Subsection of Section 825&amp;#8211;10&amp;#8211;15, to be accounted for by the equity method by the investing&#13;entity; (c.) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship&#13;of management; (d.) principal owners of the Company; (e.) management of the Company; (f.) other parties with which the Company&#13;may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that&#13;one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g.) other parties that&#13;can significantly influence the management or operating policies of the transacting parties or that have an ownership interest&#13;in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties&#13;might be prevented from fully pursuing its own separate interests.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense&#13;allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated&#13;in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall&#13;include: (a.) the nature of the relationship(s) involved; (b.) a description of the transactions, including transactions to which&#13;no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other&#13;information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c.) the dollar&#13;amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the&#13;method of establishing the terms from that used in the preceding period; and (d.) amounts due from or to related parties as of&#13;the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Subsequent&#13;Events&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s management reviewed all material events that have occurred after the balance sheet date through the date which&#13;these financial statements were issued.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Management&#13;does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material&#13;effect on the accompanying financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <macqu:InitialPublicOfferingTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;3 &amp;#8212; Initial Public Offering&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 19, 2016, the Company sold 5,000,000 Units at a price of $10.00 per Unit generating gross proceeds of $50,000,000 and&#13;net proceeds of $47,981,581 after deducting $2,018,419 of transaction costs. In addition, the Company granted the Underwriter&#13;the option to purchase an additional 750,000 Units solely to cover over allotments, if any, pursuant to a 45-day over-allotment&#13;option granted to the Underwriter. The underwriters exercised the over-allotment option in part and, on October 14, 2016, the&#13;underwriters purchased 310,109 Over-allotment Option Units, which were sold at an offering price of $10.00 per Unit, generating&#13;gross proceeds of $3,101,090 and net proceeds of $3,008,057 after deducting $93,033 of transaction costs.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Each&#13;Unit consists of one share of common stock in the Company, and one Warrant (&amp;#8220;Warrant&amp;#8221;). Each Warrant entitles the&#13;holder to purchase one share of common stock at a price of $11.50 per share commencing on the later of 30 days after the Company&amp;#8217;s&#13;completion of its initial Business Combination or September 14, 2017, and expiring five years from the completion of the Company&amp;#8217;s&#13;initial Business Combination. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days&amp;#8217; notice,&#13;only in the event that the last sale price of the common shares is at least $16.00 per share for any 20 trading days within a&#13;30-trading day period (&amp;#8220;30-Day Trading Period&amp;#8221;) ending on the third day prior to the date on which notice of redemption&#13;is given, provided there is a current registration statement in effect with respect to the common shares underlying such Warrants&#13;during the 30&amp;#160;day redemption period. If the Company redeems the Warrants as described above, management will have the option&#13;to require all holders that wish to exercise Warrants to do so on a &amp;#8220;cashless basis.&amp;#8221; In accordance with the warrant&#13;agreement relating to the Warrants to be sold and issued in the Offering the Company is only required to use its best efforts&#13;to maintain the effectiveness of the registration statement covering the Warrants. If a registration statement is not effective&#13;within 90 days following the consummation of a Business Combination, Warrant holders may, until such time as there is an effective&#13;registration statement and during any period when the Company shall have failed to maintain an effective registration statement,&#13;exercise Warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act of 1933, as&#13;amended. In the event that a registration statement is not effective at the time of exercise or no exemption is available for&#13;a cashless exercise, the holder of such Warrant shall not be entitled to exercise such Warrant for cash and in no event (whether&#13;in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the Warrant&#13;exercise. If an initial Business Combination is not consummated, the Warrants will expire and will be worthless.&lt;/font&gt;&lt;/p&gt;</macqu:InitialPublicOfferingTextBlock>
    <macqu:PrivateUnitsTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;4 &amp;#8212; Private Units&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Simultaneously&#13;with the Offering, the Initial Shareholders of the Company purchased an aggregate of 421,107 Private Units at $10.00 per Private&#13;Unit (for an aggregate purchase price of $4,211,070) from the Company.&amp;#160;All of the proceeds received from these purchases&#13;were placed in the Trust Account.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Private Units are identical to the Units sold in the Offering except the Warrants included in the Private Units will be non-redeemable&#13;and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial purchasers or their&#13;permitted transferees. Additionally, the holders of the Private Units have agreed (A) to vote the shares underlying their Private&#13;Units in favor of any proposed Business Combination, (B) not to propose, or vote in favor of, an amendment to the Company&amp;#8217;s&#13;amended and restated certificate of incorporation with respect to the Company&amp;#8217;s pre-Business Combination activities prior&#13;to the consummation of such a Business Combination unless the Company provides dissenting Public Stockholders with the opportunity&#13;to convert their public shares in connection with any such vote, (C) not to convert any shares underlying the Private Units into&#13;the right to receive cash from the Trust Account in connection with a stockholder vote to approve an initial Business Combination&#13;or a vote to amend the provisions of the Company&amp;#8217;s amended and restated certificate of incorporation relating to shareholders&amp;#8217;&#13;rights or pre-Business Combination activity or sell their shares to the Company in connection with a tender offer the Company&#13;engages in and (D) that the shares underlying the Private Units shall not participate in any liquidating distribution upon winding&#13;up if a Business Combination is not consummated. The purchasers have also agreed not to transfer, assign or sell any of the Private&#13;Units or underlying securities (except to the same permitted transferees as the insider shares and provided the transferees agree&#13;to the same terms and restrictions as the permitted transferees of the insider shares must agree to, each as described above)&#13;until the completion of an initial Business Combination.&lt;/font&gt;&lt;/p&gt;</macqu:PrivateUnitsTextBlock>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;5 &amp;#8212; Notes Payable&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Note&#13;Payable Related Party&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;June 30, 2016, the Company issued a $131,720 principal amount unsecured promissory note to an affiliate of the Company&amp;#8217;s&#13;executive officers. The note was non-interest bearing and payable on the earlier of (i) the consummation of the Offering or (ii)&#13;the date on which the Company determines not to proceed with the Offering. As of March 31, 2017, all amounts under the note had&#13;been repaid.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Advances&#13;from Related Party&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;An&#13;affiliate of the Company&amp;#8217;s executive officers advanced funds to the Company to pay administrative expenses and offering&#13;costs incurred. These advances totaled $55,201 and were due on demand and are non-interest bearing. As of March 31, 2017, the&#13;Company repaid all advances.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Note&#13;Payable&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;July 1, 2015, the Company issued a $55,000 principal amount unsecured promissory note. The note was non-interest bearing and was&#13;payable on the consummation of the Public Offering.&amp;#160;On September 26, 2016, the Company amended the agreement with lender&#13;and outstanding balance was amended to $27,500. The note is now due upon completion of an initial business combination. Due to&#13;the short-term nature of the note, the fair value of the note approximates the carrying amount.&lt;/font&gt;&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;7 &amp;#8212; Stockholder&amp;#8217;s Equity&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Preferred&#13;Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is authorized to issue 1,000,000 preferred shares with a par value of $0.001 per share with such designation, rights and&#13;preferences as may be determined from time to time by the Company&amp;#8217;s board of directors.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of March 31, 2017, there are no preferred shares issued or outstanding.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Common&#13;Stock&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Amended&#13;and Restated Certificate of Incorporation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s Certificate of Incorporation was amended in connection with the Offering to reduce the Company&amp;#8217;s authorized&#13;shares of common stock from 50,000,000 to 30,000,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is authorized to issue 30,000,000 shares of common stock with a par value of $0.001 per share.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;April 23, 2015, 1,437,500 shares of the Company&amp;#8217;s common stock were sold to the Initial Stockholders at a price of approximately&#13;$0.02 per share for an aggregate of $25,000. This number includes an aggregate of up to 187,500 shares that are subject to forfeiture&#13;if the over-allotment option is not exercised by the underwriters. All of these shares will be placed in escrow until (1) with&#13;respect to 50% of the shares, the earlier of six months after the date of the consummation of an initial Business Combination&#13;and the date on which the closing price of the Company&amp;#8217;s common stock equals or exceeds $12.50 per share (as adjusted for&#13;share splits, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period&#13;commencing after the Company&amp;#8217;s initial business combination and (2) with respect to the remaining 50% of the insider shares,&#13;six months after the date of the consummation of an initial Business Combination, or earlier, in either case, if, subsequent to&#13;an initial Business Combination, the Company consummates a liquidation, merger, share exchange or other similar transaction which&#13;results in all of the Company&amp;#8217;s stockholders having the right to exchange their shares for cash, securities or other property.&#13;On November 11, 2016, 109,973 Founders&amp;#8217; shares were forfeited and cancelled.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of March 31, 2017 and December 31, 2016, there were 2,327,728 and 2,310,710 common shares issued and outstanding, which excludes&#13;4,731,015 and 4,748,033 shares subject to possible conversion, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s insiders have agreed (A) to vote their insider shares, private shares and any public shares acquired in or after&#13;the Offering in favor of any proposed Business Combination, (B) not to propose, or vote in favor of, an amendment to the Company&amp;#8217;s&#13;certificate of incorporation that would affect the substance or timing of its obligation to redeem 100% of its public shares if&#13;it does not complete its initial business combination within 18 months from the closing of the Offering (or 21 months, as applicable),&#13;unless the Company provides its public stockholders with the opportunity to redeem their shares of common stock upon approval&#13;of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,&#13;including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise&#13;and income taxes, divided by the number of then outstanding public shares, (C) not to convert any shares (including the insider&#13;shares and private shares) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve&#13;the Company&amp;#8217;s proposed initial Business Combination (or sell any shares they hold to the Company in a tender offer in connection&#13;with a proposed initial Business Combination) or a vote to amend the provisions of the Company&amp;#8217;s certificate of incorporation&#13;relating to the substance or timing of its obligation to redeem 100% of the Company&amp;#8217;s public shares if it does not complete&#13;its initial business combination within 18 months from the closing of the Offering (or 21 months, as applicable) and (D) that&#13;the insider shares and private shares shall not be entitled to be redeemed for a pro rata portion of the funds held in the Trust&#13;Account if a Business Combination is not consummated.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Basis&#13;of presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally&#13;accepted in the United States of America (&amp;#8220;U.S. GAAP&amp;#8221;) and pursuant to the rules and regulations of the Securities&#13;and Exchange Commission (&amp;#8220;SEC&amp;#8221;) for interim financial information and the instructions to Form 10-Q. Accordingly,&#13;they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments&#13;(consisting of normal accruals) considered for a fair presentation have been included. The Company has evaluated subsequent events&#13;through the issuance of this Form 10-Q. Operating results for the quarter ended March 31, 2017 are not necessarily indicative&#13;of the results that may be expected for the year ended December 31, 2017 or any future interim period. The accompanying unaudited&#13;condensed financial statements should be read in conjunction with the Company&amp;#8217;s financial statements and notes thereto included&#13;in the Company&amp;#8217;s Form 10-K filed with the Securities and Exchange Commission on March 13, 2017.&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <macqu:EmergingGrowthCompanyPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Emerging&#13;Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Section&#13;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting&#13;standards until private companies (that is, those that have not had a Securities Act registration statement declared effective&#13;or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial&#13;accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with&#13;the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has&#13;elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different&#13;application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard&#13;at the time private companies adopt the new or revised standard. This may make comparison of the Company&amp;#8217;s financial statement&#13;with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of&#13;using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/font&gt;&lt;/p&gt;</macqu:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Cash&#13;and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.&lt;/font&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Marketable&#13;securities held in Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;amounts held in the Trust Account represent substantially all of the proceeds of the Initial Public Offering and are classified&#13;as restricted assets since such amounts can only be used by the Company in connection with the consummation of a Business Combination.&#13;As of March 31, 2017, marketable securities held in the Trust Account consisted of $54,716,747 in United States Treasury Bills&#13;with an original maturity of six months or less. During the three months ended March 31, 2017, the Company withdrew interest income&#13;totaling $71,702 to be utilized for payment of tax obligations.&lt;/font&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Fair&#13;value of financial instruments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of the Company&amp;#8217;s assets and liabilities, which qualify as financial instruments under Financial Accounting Standards&#13;Board (&amp;#8220;FASB&amp;#8221;) Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) 820, &amp;#8220;&lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;,&amp;#8221;&#13;approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/font&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Deferred&#13;Offering Costs&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (&amp;#8220;SAB&amp;#8221;) Topic 5A&amp;#8212;&amp;#8220;&lt;i&gt;Expenses&#13;of Offering&lt;/i&gt;.&amp;#8221; Deferred offering costs consist of costs incurred in connection with preparation for the Offering. These&#13;costs, together with the underwriter discount, were charged to capital upon completion of the Offering.&lt;/font&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Use&#13;of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect&#13;the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial&#13;statements. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Concentration&#13;of credit risk&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Financial&#13;instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution&#13;which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these&#13;accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Net&#13;Loss Per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;loss per common share is computed by dividing net loss applicable to common stockholders by the weighted average number of common&#13;shares outstanding during the period, plus, to the extent dilutive, the incremental number of shares of common stock to settle&#13;warrants, as calculated using the treasury stock method. An aggregate of 4,731,015 shares of common stock subject to possible&#13;redemption at March 31, 2017 and an aggregate of 187,500 shares subject to forfeiture if the over-allotment option was not exercised&#13;in full by the underwriters at March 31, 2016, have been excluded from the calculation of basic loss per ordinary share since&#13;such shares, if redeemed, only participate in their pro rata share of the trust earnings.&amp;#160;At March 31, 2017, the Company&#13;did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock&#13;and then share in the earnings of the Company under the treasury stock method. As a result, diluted loss per common share is the&#13;same as basic loss per common share for the period.&lt;/font&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <macqu:CommonStockSubjectToPossibleConversionPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Common&#13;stock subject to possible conversion&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for its common stock subject to possible conversion in accordance with the guidance enumerated in ASC 480 &amp;#8220;&lt;i&gt;Distinguishing&#13;Liabilities from Equity&lt;/i&gt;&amp;#8221;.&amp;#160;&amp;#160;&amp;#160;Common stock subject to mandatory conversion are classified as a liability&#13;instrument and is measured at fair value. Conditionally convertible common stock (including common shares that feature conversion&#13;rights that are either within the control of the holder or subject to conversion upon the occurrence of uncertain events not solely&#13;within the Company&amp;#8217;s control) is classified as temporary equity. At all other times, common stock is classified as stockholders&amp;#8217;&#13;equity. The Company&amp;#8217;s common stock features certain conversion rights that are considered by the Company to be outside of&#13;the Company&amp;#8217;s control and subject to the occurrence of uncertain future events. Accordingly, the common stock subject to&#13;possible conversion is presented as temporary equity, outside of the stockholders&amp;#8217; equity section of the Company&amp;#8217;s&#13;condensed balance sheet.&lt;/font&gt;&lt;/p&gt;</macqu:CommonStockSubjectToPossibleConversionPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Income&#13;Taxes&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for income taxes under ASC 740 &amp;#8220;&lt;i&gt;Income Taxes&lt;/i&gt;&amp;#8221;. ASC 740 requires the recognition of deferred&#13;tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets&#13;and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally&#13;requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets&#13;will not be realized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ASC&#13;740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&amp;#8217;s financial statements and&#13;prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position&#13;taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not&#13;to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest&#13;and penalties, accounting in interim periods, disclosure and transition. The Company is required to file income tax returns in&#13;the United States (federal) and in various state and local jurisdictions. Based on the Company&amp;#8217;s evaluation, it has been&#13;concluded that there are no significant uncertain tax positions requiring recognition in the Company&amp;#8217;s financial statements.&#13;Since the Company was incorporated on April 23, 2015, the evaluation was performed for the 2015 and 2016 tax year. The Company&#13;believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that&#13;would result in a material change to its financial position.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s policy for recording interest and penalties associated with audits is to record such expense as a component of&#13;income tax expense. There were no amounts accrued for penalties or interest as of or during the period from January 1, 2017 through&#13;March 31, 2017. Management is currently unaware of any issues under review that could result in significant payments, accruals&#13;or material deviations from its position.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <macqu:RelatedPartiesPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Related&#13;Parties&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company follows subtopic ASC 850-10 for the identification of related parties and disclosure of related party transactions.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Pursuant&#13;to Section 850-10-20, the related parties include: (a.) affiliates of the Company (&amp;#8220;Affiliate&amp;#8221; means, with respect&#13;to any specified Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled&#13;by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act);&#13;(b.) entities for which investments in their equity securities would be required, absent the election of the fair value option&#13;under the Fair Value Option Subsection of Section 825&amp;#8211;10&amp;#8211;15, to be accounted for by the equity method by the investing&#13;entity; (c.) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship&#13;of management; (d.) principal owners of the Company; (e.) management of the Company; (f.) other parties with which the Company&#13;may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that&#13;one of the transacting parties might be prevented from fully pursuing its own separate interests; and (g.) other parties that&#13;can significantly influence the management or operating policies of the transacting parties or that have an ownership interest&#13;in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties&#13;might be prevented from fully pursuing its own separate interests.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense&#13;allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated&#13;in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall&#13;include: (a.) the nature of the relationship(s) involved; (b.) a description of the transactions, including transactions to which&#13;no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other&#13;information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c.) the dollar&#13;amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the&#13;method of establishing the terms from that used in the preceding period; and (d.) amounts due from or to related parties as of&#13;the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.&lt;/font&gt;&lt;/p&gt;</macqu:RelatedPartiesPolicyTextBlock>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Subsequent&#13;Events&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s management reviewed all material events that have occurred after the balance sheet date through the date which&#13;these financial statements were issued.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Management&#13;does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material&#13;effect on the accompanying financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">54966023</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">55150604</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">5000006</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">5000006</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">-307066</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-118221</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">5304744</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">5115916</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:CommonStockValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">2328</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">2311</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2017-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">48749608</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">48938449</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:Liabilities contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">1216409</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">1212149</us-gaap:Liabilities>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">1062022</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">1062022</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">154387</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">150127</us-gaap:LiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">27500</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">27500</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2015-07-01_custom_UnsecuredDebt1Member" unitRef="USD" decimals="0">27500</us-gaap:NotesPayableCurrent>
    <macqu:AccruedOfferingCostsPayable contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">11616</macqu:AccruedOfferingCostsPayable>
    <macqu:AccruedOfferingCostsPayable contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">11616</macqu:AccruedOfferingCostsPayable>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">115271</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">111011</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:Assets contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">54966023</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">55150604</us-gaap:Assets>
    <macqu:CashAndCashEquivalentsHeldInTrust contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">54716747</macqu:CashAndCashEquivalentsHeldInTrust>
    <macqu:CashAndCashEquivalentsHeldInTrust contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">54731828</macqu:CashAndCashEquivalentsHeldInTrust>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">121205</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">56241</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <macqu:CommonStockSharesAuthorizedPreviously contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">50000000</macqu:CommonStockSharesAuthorizedPreviously>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2015-04-22to2015-04-23_custom_InitialStockholdersMember" unitRef="Shares" decimals="INF">1437500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-09-18to2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="Shares" decimals="INF">421107</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-09-18to2016-09-19_us-gaap_IPOMember" unitRef="Shares" decimals="INF">5000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2016-09-18to2016-09-19_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" unitRef="Shares" decimals="INF">750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2015-04-23_custom_InitialStockholdersMember" unitRef="USDPShares" decimals="INF">0.02</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2016-09-19_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-03-31_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">10.30</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-03-31_us-gaap_PrivatePlacementMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MinimumMember" unitRef="USDPShares" decimals="INF">0.025</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MaximumMember" unitRef="USDPShares" decimals="INF">0.075</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2015-04-22to2015-04-23_custom_InitialStockholdersMember" unitRef="USD" decimals="0">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <macqu:MaximumNumberOfSharesForfeiture contextRef="From2015-04-22to2015-04-23_us-gaap_OverAllotmentOptionMember_custom_InitialStockholdersMember" unitRef="Shares" decimals="INF">187500</macqu:MaximumNumberOfSharesForfeiture>
    <macqu:MaximumNumberOfSharesForfeiture contextRef="From2016-01-01to2016-03-31_us-gaap_OverAllotmentOptionMember" unitRef="Shares" decimals="INF">187500</macqu:MaximumNumberOfSharesForfeiture>
    <macqu:DescriptionOfEscrowShares contextRef="From2015-04-22to2015-04-23_us-gaap_OverAllotmentOptionMember_custom_InitialStockholdersMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1) with respect to 50% of the shares, the earlier&#13;of six months after the date of the consummation of an initial Business Combination and the date on which the closing price of&#13;the Company&amp;#8217;s common stock equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, reorganizations&#13;and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company&amp;#8217;s initial business&#13;combination and (2) with respect to the remaining 50% of the insider shares, six months after the date of the consummation of&#13;an initial Business Combination, or earlier, in either case, if, subsequent to an initial Business Combination, the Company consummates&#13;a liquidation, merger, share exchange or other similar transaction which results in all of the Company&amp;#8217;s stockholders having&#13;the right to exchange their shares for cash, securities or other property.&lt;/font&gt;&lt;/p&gt;</macqu:DescriptionOfEscrowShares>
    <macqu:NumberOfSharesExcludesSubjectToPossibleConversion contextRef="AsOf2017-03-31" unitRef="Shares" decimals="INF">4731015</macqu:NumberOfSharesExcludesSubjectToPossibleConversion>
    <macqu:NumberOfSharesExcludesSubjectToPossibleConversion contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">4748033</macqu:NumberOfSharesExcludesSubjectToPossibleConversion>
    <macqu:NumberOfSharesForfeitedAndCancelled contextRef="From2016-11-10to2016-11-11_custom_FoundersSharesMember" unitRef="Shares" decimals="INF">109973</macqu:NumberOfSharesForfeitedAndCancelled>
    <macqu:PercentageOfUnderwritingDiscountOnOfferingGrossProceeds contextRef="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember" unitRef="Pure" decimals="INF">0.03</macqu:PercentageOfUnderwritingDiscountOnOfferingGrossProceeds>
    <macqu:MaximumDeferredUnderwritingDiscount contextRef="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember" unitRef="Pure" decimals="INF">0.02</macqu:MaximumDeferredUnderwritingDiscount>
    <macqu:AggregateUnderwritingDiscount contextRef="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember" unitRef="Pure" decimals="INF">0.05</macqu:AggregateUnderwritingDiscount>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember_custom_MSPACHoldingsILLCMember" unitRef="Shares" decimals="INF">63184</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <macqu:PercentageOfWarrantSolicitationFee contextRef="From2017-01-01to2017-03-31_custom_UnderwritingAgreementMember_custom_ChardanCapitalMarketsLLCMember" unitRef="Pure" decimals="INF">0.05</macqu:PercentageOfWarrantSolicitationFee>
    <macqu:CashReceiptForOffering contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="USD" decimals="0">100</macqu:CashReceiptForOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="Shares" decimals="INF">300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2016-10-12to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_InitialStockholdersMember" unitRef="Shares" decimals="INF">18607</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2016-10-13to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" unitRef="Shares" decimals="INF">310109</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2016-09-18to2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="Shares" decimals="INF">402500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2016-09-18to2016-09-19_us-gaap_IPOMember" unitRef="Shares" decimals="INF">5000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="USDPShares" decimals="INF">12.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="USD" decimals="0">3600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2016-10-12to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_InitialStockholdersMember" unitRef="USD" decimals="0">186070</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2016-10-13to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" unitRef="USD" decimals="0">3101090</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2016-09-18to2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="USD" decimals="0">4025000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2016-09-18to2016-09-19_us-gaap_IPOMember" unitRef="USD" decimals="0">50000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="From2017-01-01to2017-03-31_us-gaap_IPOMember_custom_TrustAccountMember" unitRef="USD" decimals="0">54694127</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <macqu:SaleOfStockExpirationPeriod contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember">P5Y</macqu:SaleOfStockExpirationPeriod>
    <macqu:SaleOfStockExpirationPeriod contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember_custom_DemandAndPiggyBackRegistrationRightsMember_us-gaap_MinimumMember">P3Y</macqu:SaleOfStockExpirationPeriod>
    <macqu:SaleOfStockExpirationPeriod contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember_custom_DemandAndPiggyBackRegistrationRightsMember_us-gaap_MaximumMember">P5Y</macqu:SaleOfStockExpirationPeriod>
    <macqu:FairValue contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="USD" decimals="0">2695000</macqu:FairValue>
    <us-gaap:SharePrice contextRef="AsOf2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="USDPShares" decimals="INF">8.98</us-gaap:SharePrice>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="Pure" decimals="INF">1.49</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember" unitRef="Pure" decimals="INF">0.0122</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2017-01-01to2017-03-31_custom_UnitPurchaseOptionMember_custom_UnderwritersMember">P5Y</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2016-10-13to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" unitRef="USD" decimals="0">3008057</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2016-09-18to2016-09-19_us-gaap_IPOMember" unitRef="USD" decimals="0">47981581</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2016-10-13to2016-10-14_us-gaap_OverAllotmentOptionMember_custom_UnderwritersMember" unitRef="USD" decimals="0">93033</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2016-09-18to2016-09-19_us-gaap_IPOMember" unitRef="USD" decimals="0">2018419</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2017-01-01to2017-03-31_us-gaap_IPOMember" unitRef="USD" decimals="0">54694127</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MinimumMember" unitRef="USD" decimals="0">132753</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember_us-gaap_MaximumMember" unitRef="USD" decimals="0">398259</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2017-03-31_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="USD" decimals="0">1169032</us-gaap:DeferredFinanceCostsNet>
    <macqu:DeferredUnderwritingFee contextRef="From2017-01-01to2017-03-31_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="USD" decimals="0">1062022</macqu:DeferredUnderwritingFee>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts contextRef="AsOf2017-03-31_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">200000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">5000001</us-gaap:BusinessCombinationAssetsArisingFromContingenciesAmountRecognized>
    <macqu:PercentageOfConversionRights contextRef="AsOf2017-03-31" unitRef="Pure" decimals="INF">0.20</macqu:PercentageOfConversionRights>
    <macqu:PercentageOfSharesSold contextRef="AsOf2017-03-31" unitRef="Pure" decimals="INF">0.20</macqu:PercentageOfSharesSold>
    <us-gaap:SecurityDeposit contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">398259</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit contextRef="AsOf2017-03-31_custom_AffiliatesMember" unitRef="USD" decimals="0">398259</us-gaap:SecurityDeposit>
    <macqu:CostsOfLiquidation contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">15000</macqu:CostsOfLiquidation>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember" unitRef="USD" decimals="0">56600</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="From2017-01-01to2017-03-31_custom_TrustAgreementMember_custom_TrustAccountMember" unitRef="USD" decimals="0">95000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:MarketableSecurities contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">54716747</us-gaap:MarketableSecurities>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2017-01-01to2017-03-31_us-gaap_USTreasurySecuritiesMember_custom_TrustAccountMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;An original maturity of six months or less.&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentMaturityDateDescription>
    <macqu:DescriptionInitialPublicOffering contextRef="From2016-09-18to2016-09-19_us-gaap_IPOMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Each Unit consists of one share of common stock in&#13;the Company, and one Warrant (&amp;#8220;Warrant&amp;#8221;). Each Warrant entitles the holder to purchase one share of common stock at&#13;a price of $11.50 per share commencing on the later of 30 days after the Company&amp;#8217;s completion of its initial Business Combination&#13;or &lt;a name="a_DV_C1371"&gt;&lt;/a&gt;September 14, 2017, and expiring five years from the completion of the Company&amp;#8217;s initial Business&#13;Combination. The Company may redeem the Warrants at a price of $0.01 per Warrant upon 30 days&amp;#8217; notice, only in the event&#13;that the last sale price of the common shares is at least $16.00 per share for any 20 trading days within a 30-trading day period&#13;(&amp;#8220;30-Day Trading Period&amp;#8221;) ending on the third day prior to the date on which notice of redemption is given, provided&#13;there is a current registration statement in effect with respect to the common shares underlying such Warrants during the 30&amp;#160;day&#13;redemption period.&lt;/font&gt;&lt;/p&gt;</macqu:DescriptionInitialPublicOffering>
    <macqu:GrossProceedsFromIssuanceInitialPublicOffering contextRef="From2016-09-18to2016-09-19_us-gaap_PrivatePlacementMember_custom_InitialStockholdersMember" unitRef="USD" decimals="0">4211070</macqu:GrossProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-06-30_us-gaap_UnsecuredDebtMember_us-gaap_AffiliatedEntityMember" unitRef="USD" decimals="0">131720</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2015-07-01_custom_UnsecuredDebt1Member" unitRef="USD" decimals="0">55000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2015-06-29to2015-07-01_custom_UnsecuredDebt1Member">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-interest bearing&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2017-01-01to2017-03-31_us-gaap_LoansPayableMember_us-gaap_AffiliatedEntityMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-interest bearing&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2016-06-28to2016-06-30_us-gaap_UnsecuredDebtMember_us-gaap_AffiliatedEntityMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-interest bearing&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentInterestRateTerms>
    <us-gaap:DebtInstrumentPaymentTerms contextRef="From2015-06-29to2015-07-01_custom_UnsecuredDebt1Member">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The consummation of the Public Offering.&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentPaymentTerms contextRef="From2017-01-01to2017-03-31_us-gaap_LoansPayableMember_us-gaap_AffiliatedEntityMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Due on demand&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentPaymentTerms contextRef="From2016-06-28to2016-06-30_us-gaap_UnsecuredDebtMember_us-gaap_AffiliatedEntityMember">&lt;p&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Payable on the earlier of (i) the consummation of&#13;the Offering or (ii) the date on which the Company determines not to proceed with the Offering.&lt;/font&gt;&lt;/p&gt;</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-03-31_us-gaap_LoansPayableMember_us-gaap_AffiliatedEntityMember" unitRef="USD" decimals="0">55201</us-gaap:RepaymentsOfRelatedPartyDebt>
    <macqu:InvestmentIncomeInterest1 contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="0">71702</macqu:InvestmentIncomeInterest1>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2017-01-01to2017-03-31">&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Note&#13;6 &amp;#8212; Commitments&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Underwriting&#13;Agreement&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company entered into an agreement with the underwriters of the Offering (&amp;#8220;Underwriting Agreement&amp;#8221;). The Underwriting&#13;Agreement required the Company to pay an underwriting discount of 3.0% of the gross proceeds of the Offering as an underwriting&#13;discount and incur a deferred underwriting discount of up to 2.0% for an aggregate underwriting discount of 5.0% of the gross&#13;proceeds of the Offering, in each case as set forth in the Underwriting Agreement. The Company will pay the deferred underwriting&#13;fee at the closing of the Business Combination. The underwriters also purchased an interest in M SPAC Holdings I LLC, an entity&#13;controlled by the Company&amp;#8217;s insiders, which entitles it to a beneficial interest in 63,184 insider shares.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Underwriting Agreement granted Chardan Capital Markets, LLC a right of first refusal, for a period of thirty-six months from the&#13;closing of the Offering, to act as lead investment banker, lead book-runner, and/or lead placement agent with 33% of the economics&#13;or 25% if three investment banks are involved in the transaction, for any public or private equity and debt offerings during such&#13;period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Underwriting Agreement will provide that the Company will pay Chardan Capital Markets, LLC a warrant solicitation fee of five&#13;percent (5%) of the exercise price of each public warrant exercised during the period commencing on the later of 12 months from&#13;the closing of the Proposed Public Offering or 30 days after the completion of the Company&amp;#8217;s initial business combination&#13;including warrants acquired by security holders in the open market. The warrant solicitation fee will be payable in cash. There&#13;is no limitation on the maximum warrant solicitation fee payable to Chardan Capital Markets, LLC except to the extent it is limited&#13;by the number of warrants outstanding.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Purchase&#13;Option&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company sold to the underwriters, for $100, a unit purchase option to purchase up to a total of 300,000 units exercisable at $12.00&#13;per unit (or an aggregate exercise price of $3,600,000) commencing on the later of the consummation of a Business Combination&#13;and six months from September 13, 2016. The unit purchase option expires five years from September 13, 2016. The units issuable&#13;upon exercise of this option are identical to the Units being offered in the Offering. The Company has agreed to grant to the&#13;holders of the unit purchase option, demand and &amp;#8220;piggy back&amp;#8221; registration rights for periods of five and seven years,&#13;respectively, from September 13, 2016, including securities directly and indirectly issuable upon exercise of the unit purchase&#13;option.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for the fair value of the unit purchase option, inclusive of the receipt of a $100 cash payment, as an expense&#13;of the Offering resulting in a charge directly to stockholders&amp;#8217; equity. The Company estimates that the fair value of this&#13;unit purchase option was approximately $2,695,000 (or $8.98 per unit) using a Black-Scholes option-pricing model. The fair value&#13;of the unit purchase option to be granted to the placement agent is estimated as of the date of grant using the following assumptions:&#13;(1) expected volatility of 149%, (2) risk-free interest rate of 1.22% and (3) expected life of five years. The unit purchase option&#13;may be exercised for cash or on a &amp;#8220;cashless&amp;#8221; basis, at the holder&amp;#8217;s option (except in the case of a forced cashless&#13;exercise upon the Company&amp;#8217;s redemption of the Warrants, as described in Note 3), such that the holder may use the appreciated&#13;value of the unit purchase option (the difference between the exercise prices of the unit purchase option and the underlying Warrants&#13;and the market price of the Units and underlying common stock) to exercise the unit purchase option without the payment of any&#13;cash. The Company will have no obligation to net cash settle the exercise of the unit purchase option or the Warrants underlying&#13;the unit purchase option. The holder of the unit purchase option will not be entitled to exercise the unit purchase option or&#13;the Warrants underlying the unit purchase option unless a registration statement covering the securities underlying the unit purchase&#13;option is effective or an exemption from registration is available. If the holder is unable to exercise the unit purchase option&#13;or underlying Warrants, the unit purchase option or Warrants, as applicable, will expire worthless.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Registration&#13;Rights&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Initial Stockholders are entitled to registration rights with respect to their initial shares and the purchasers of the Private&#13;Units will be entitled to registration rights with respect to the Private Units (and underlying securities), pursuant to an agreement&#13;signed on September 13, 2016. The holders of the majority of the initial shares are entitled to demand that the Company register&#13;these shares at any time commencing three months prior to the first anniversary of the consummation of a Business Combination.&#13;The holders of the Private Units (or underlying securities) are entitled to demand that the Company register these securities&#13;at any time after the Company consummates a Business Combination. In addition, the holders have certain &amp;#8220;piggy-back&amp;#8221;&#13;registration rights on registration statements filed after the Company&amp;#8217;s consummation of a Business Combination.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Administrative&#13;Service Fee&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company, commencing on September 13, 2016, has agreed to pay an affiliate of the Company&amp;#8217;s executive officers a monthly&#13;fee of $10,000 for general and administrative services due on the first of each month. During the three months ended March 31,&#13;2017 and 2016, the Company incurred administrative fees of $30,000 and $0, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April 2017, the Company and its Sponsor have agreed to defer payment of the monthly administrative service fee.&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="0">249276</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">418776</us-gaap:AssetsCurrent>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">This number excludes an aggregate of of 4,731,015 subject to possible conversion at March 31, 2017 and 187,500 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
